Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01113684 · ClinicalTrials.gov registry record

Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
175
Enrollment target

NCT01113684: Completed study, sponsored by University of Alabama at Birmingham.

NCT01113684 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01113684 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
175 participants
Enrollment target

Study Summary

Deep brain stimulation (DBS) improves debilitating symptoms of movement disorders when conventional medical therapies and novel surgical therapies fail. Despite the remarkable efficacy of DBS, its therapeutic mechanism remains unclear. There is controversy regarding whether the therapeutic effects of DBS are associated with inhibition or excitation of target neurons, the introduction of new activity into the network, or a combination of these mechanisms. Additionally, it is unclear why stimulus frequency plays an important role in the clinical response to therapy. The fundamental hypothesis of this proposal is that unilateral subthalamic nucleus (STN) DBS in PD alters neuronal activity in the bilateral basal ganglia-thalamic-cortical motor system in a manner that is dependent on stimulation frequency.

Interventions

  • DEVICE Implantable pulse generator (deep brain stimulator)

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2010-02
Est. Completion 2014-11
University of Alabama at Birmingham

1,160 total trials

What the finished NCT01113684 record still lists

NCT01113684 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Implantable pulse generator (deep brain stimulator) is the first listed.

NCT01113684 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01113684 about?

NCT01113684 is a clinical study titled "Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)". Deep brain stimulation (DBS) improves debilitating symptoms of movement disorders when conventional medical therapies and novel surgical therapies fail. Despite the remarkable efficacy of DBS, its therapeutic mechanism remains unclear. There is controversy regarding whether the therapeutic effects o...

What is the current status of trial NCT01113684?

This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-02. Estimated completion is 2014-11.

What interventions are being tested in trial NCT01113684?

The interventions under investigation include: Implantable pulse generator (deep brain stimulator) (DEVICE).

Who is sponsoring clinical trial NCT01113684?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01113684, the US trial registry maintained by the National Library of Medicine. NCT01113684 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.